Uncertainty about U.S. trade tariffs and persistent portfolio outflows have hurt the rupee over the last two months and made ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled improvement ...

Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced the 2025 ...

Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced receipt of revised regulatory ...